In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides

Author： Sheng-hua Chu   Zhi-an Zhu   Xian-hou Yuan   Zhi-qiang Li   Pu-cha Jiang  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.80, Iss.2, 2006-11, pp. : 143-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overexpression of cMet increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo

By          

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1618-1624

Spandidos Publications

Access to resources Recommend Favorite

Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 4, 2013-01 ,pp. : 595-602

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibiting effect of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotides on VEGF expression in U937 cells

By He Xiaoyan   Tong Yunjie   Zhang Min   Zou Ping  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 420-422

Springer Publishing Company

Access to resources Recommend Favorite

FOXP1 has a low expression in human gliomas and its overexpression inhibits proliferation, invasion and migration of human glioma U251 cells

By Xue Liang   Yue Shuyuan   Zhang Jianning  

Molecular Medicine Reports, Vol. 10, Iss. 1, 2014-07 ,pp. : 467-472

Spandidos Publications

Access to resources Recommend Favorite

An antisense EGFR oligodeoxynucleotide enveloped in lipofectin^Rinduces growth inhibition in human malignant gliomas in vitro

By Sugawa N.   Ueda S.   Nakagawa Y.   Nishino H.   Nosaka K.   Iwashima A.   Kurimoto M.  

Journal of Neuro-Oncology, Vol. 39, Iss. 3, 1998-09 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite